Search results
Results from the WOW.Com Content Network
Amylin Pharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes , obesity , and other diseases.
Bloomberg, the exclusive media outlet of Amylin Pharmaceuticals' (NAS: AMLN) rumor-leaking department, published a report on Friday that Sanofi and Merck (NYS: MRK) have put in bids to buy the ...
What: Shares of biotechnology company Amylin. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
What: Shares of Amylin Pharmaceuticals (NAS: AMLN) Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they ...
Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). [1] Pramlintide is sold as an acetate salt.
What: Shares of biotechnology company Amylin. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Amylin, or islet amyloid polypeptide (IAPP), is a 37-residue peptide hormone. [5] It is co-secreted with insulin from the pancreatic β-cells in the ratio of approximately 100:1 (insulin:amylin). Amylin plays a role in glycemic regulation by slowing gastric emptying and promoting satiety, thereby preventing post-prandial spikes in blood glucose ...
What: Shares of Amylin Pharmaceuticals (NAS: AMLN) Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they ...